Search

Search bills, members, committees and pages...

Sign In

AEGIS LLC

PreviousNext

18 federal lobbying filings, 2024 to 2026.

AEGIS LLC is a registrant on 18 federal lobbying filings, 2024 to 2026, reporting $880K across them.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Clients

2 who it filed for, by filings.

ClientFilingsReported
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA9$480K
TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS THERAPEUTICS FKA TRIS9$400K

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20264$220K—
20258$440K—
20246$220K—

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
PHAPharmacy18
HCRHealth Issues10

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1227Alternatives to PAIN Act6
H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…6
H.R. 5376Impacts and Outcomes for Health Career Training Act6
H.R. 5378Tribal Healthcare Careers Act6
H.R. 6283FOSTER Act6
H.R. 830SAFE Act6
S. 1542Uyghur Policy Act of 20266
S. 475Alternatives to PAIN Act6

Lobbyists

Named on the filings.

LobbyistClientsFilings
ANNE ESPOSITO218

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS THERAPEUTICS FKA TRISAEGIS LLC2026 second_quarter$50KJul 2, 2026
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAAEGIS LLC2026 second_quarter$60KJul 2, 2026
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAAEGIS LLC2026 first_quarter$60KApr 7, 2026
TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS THERAPEUTICS FKA TRISAEGIS LLC2026 first_quarter$50KApr 7, 2026
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAAEGIS LLC2025 fourth_quarter$60KJan 12, 2026
TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS THERAPEUTICS FKA TRISAEGIS LLC2025 fourth_quarter$50KJan 12, 2026
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAAEGIS LLC2025 third_quarter$60KOct 10, 2025
TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS THERAPEUTICS FKA TRISAEGIS LLC2025 third_quarter$50KOct 10, 2025
TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS THERAPEUTICS FKA TRISAEGIS LLC2025 second_quarter$50KJul 18, 2025
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAAEGIS LLC2025 second_quarter$60KJul 18, 2025
TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS THERAPEUTICS FKA TRISAEGIS LLC2025 first_quarter$50KApr 4, 2025
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAAEGIS LLC2025 first_quarter$60KApr 4, 2025
TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS THERAPEUTICS FKA TRISAEGIS LLC2024 fourth_quarter$50KJan 16, 2025
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAAEGIS LLC2024 fourth_quarter$60KJan 16, 2025
TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS THERAPEUTICS FKA TRISAEGIS LLC2024 third_quarter$50KOct 3, 2024
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAAEGIS LLC2024 third_quarter$60KOct 3, 2024
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAAEGIS LLC2024 third_quarter—Jul 23, 2024
TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS THERAPEUTICS FKA TRISAEGIS LLC2024 third_quarter—Jul 23, 2024